Lifeboat Foundation

In a series of quadrotor closed-loop control experiments, the drones underwent range tests, stress tests, target rotation and occlusion, hiking with adversaries, triangular loops between objects, and dynamic target tracking. They tracked moving targets, and executed multi-step loops between objects in never-before-seen environments, surpassing performance of other cutting-edge counterparts.

The team believes that the ability to learn from limited expert data and understand a given task while generalizing to new environments could make autonomous drone deployment more efficient, cost-effective, and reliable. Liquid neural networks, they noted, could enable autonomous air mobility drones to be used for environmental monitoring, package delivery, autonomous vehicles, and robotic assistants.

“The experimental setup presented in our work tests the reasoning capabilities of various deep learning systems in controlled and straightforward scenarios,” says MIT CSAIL Research Affiliate Ramin Hasani. “There is still so much room left for future research and development on more complex reasoning challenges for AI systems in autonomous navigation applications, which has to be tested before we can safely deploy them in our society.”

As part of our SLAS US 2023 coverage, we speak to Luigi Da Via, Team Leader in Analytical Development at GSK, about the lab of the future, and what it may look like.

Please, can you introduce yourself and tell us what inspired your career within the life sciences?

Hello, my name is Luigi Da Via, and I am currently leading the High-Throughput Automation team at GSK. I have been with the company for the past six years, and I’m thrilled to be contributing to the development of life-saving medicines through the application of cutting-edge technology and automation.

Technology As A Force For Good In People’s Lives — Dr. Emre Ozcan, PhD, VP, Global Head of Digital Health & Walid Mehanna, Group Data Officer And Senior Vice President, Merck KGaA, Darmstadt, Germany.

EPISODE DISCLAIMER — At any time during this episode when anyone says Merck, in any context, it shall always be referring to Merck KGaA, Darmstadt, Germany.

Continue reading “Dr. Emre Ozcan & Walid Mehanna — Merck KGaA, Darmstadt, Germany — Tech As A Force For Good In Health” »

EPISODE DISCLAIMER — The views and opinions expressed in this episode are those of the guest and do not necessarily reflect the views or positions of any entities they represent.

Dr. Devi SenGupta, MD, MPhil, is Executive Director of Clinical Development at Gilead Sciences (https://www.gilead.com/), where she leads the company’s HIV cure development program and during her time at the company has led multiple HIV treatment and cure studies. As head of the HIV cure program, she provides strategic direction for cross-functional internal teams and external multi-stakeholder collaborations developing combination approaches aimed at achieving long-term HIV remission.

Continue reading “Dr. Devi SenGupta, MD, MPhil — Executive Director of Clinical Development, Gilead Sciences” »

Summary: For the first time, Google Quantum AI has observed the peculiar behavior of non-Abelian anyons, particles with the potential to revolutionize quantum computing by making operations more resistant to noise.

Non-Abelian anyons have the unique feature of retaining a sort of memory, allowing us to determine when they have been exchanged, even though they are identical.

The team successfully used these anyons to perform quantum computations, opening a new path towards topological quantum computation. This significant discovery could be instrumental in the future of fault-tolerant topological quantum computing.

OTTAWA, May 15 (Reuters) — Automaker Stellantis (STLAM.MI) has stopped all construction at a more-than C$5 billion ($3.74 billion) electric vehicle battery manufacturing plant in Windsor, Canada, over a disagreement with the federal government about subsidies, a spokesperson for the company said on Monday.

“Effective immediately, all construction related to the battery module production on the Windsor site has stopped,” the spokesperson said.

Canada’s industry ministry did not immediately respond to a request for comment.

Kathy Lueders, the most recent top human spaceflight official at NASA, has joined Elon Musk’s SpaceX after retiring from the agency a couple of weeks ago, CNBC has learned.

Lueders’ role will be general manager, and she will work out of the company’s “Starbase” facility in Texas, reporting directly to SpaceX president and COO Gwynne Shotwell, people familiar with the matter told CNBC.

It’s a key hire for SpaceX as the company aims to make its massive Starship rocket safe to fly people in the coming years. Lueders, a respected expert in the sector, is already familiar with the company’s human spaceflight work to date.

A commercial space station called Orbital Reef may be deployed this decade, one of many planned for low-Earth orbit.

In Part 1 looking at LEO space station deployment we focus on two front runners: the Axiom Space Station and Blue Origin’s Orbital Reef.

Dibaryons are subatomic particles composed of two baryons. Their formation, which occurs through interactions between baryons, is fundamental in big-bang nucleosynthesis, nuclear reactions including those happening within stars, and bridges the gap between nuclear physics, cosmology, and astrophysics. Fascinatingly, the strong force, responsible for the formation and the majority of the mass of nuclei, facilitates the formation of a plethora of different dibaryons with diverse quark combinations.

Nevertheless, these dibaryons are not commonly observed — the deuteron is currently the only known stable dibaryon.

To resolve this apparent dichotomy, it is essential to investigate dibaryons and baryon-baryon interactions at the fundamental level of strong interactions. In a recent publication in Physical Review Letters.